CCM
IRD

Condor Capital Management’s Opus Genetics IRD Stock Holding History

Condor Capital Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-302
Closed -$30K – 190
2016
Q3 		$30K Hold
302
– – 0.01% 187
2016
Q2 		$36K Hold
302
– – 0.01% 183
2016
Q1 		$48K Buy
+302
New +$50.3K 0.01% 184
2015
Q4 		– Sell
-440
Closed -$110K – 194
2015
Q3 		$110K Hold
440
– – 0.03% 182
2015
Q2 		$128K Hold
440
– – 0.03% 185
2015
Q1 		$154K Buy
440
+187
+74% +$67.9K 0.04% 183
2014
Q4 		$85K Sell
253
-119
-32% -$41.1K 0.02% 170
2014
Q3 		$145K Buy
372
+132
+55% +$47.5K 0.04% 164
2014
Q2 		$100K Buy
+240
New +$109K 0.03% 168

Other funds holding IRD

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Condor Capital Management's IRD Position: Q4 2016 in Review

Condor Capital Management sold out of Opus Genetics (IRD) in Q4 2016, closing a stake of 302 shares — an estimated $30K sold.

Condor Capital Management first reported a position in IRD in Q2 2014 and held it in 9 quarters. The position peaked at $154K in Q1 2015. 31 funds tracked by Wall St. Rank hold IRD as of Q4 2016.

  • Condor Capital Management reported no remaining Opus Genetics position as of Q4 2016 after selling out during the quarter.
  • Condor Capital Management sold 302 Opus Genetics shares in Q4 2016, an estimated $30K.
  • Condor Capital Management first reported a position in Opus Genetics in Q2 2014 and held it in 9 quarters.
  • Condor Capital Management's Opus Genetics position peaked at $154K in Q1 2015.
  • 31 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2016.

Based on Condor Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.